These results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two assist the notion of focusing on ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders. A exploration review published in https://helenb061hft0.azzablog.com/profile